Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Dan

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Pharmacology Research & Perspectives|April 29, 2024
Prediction of cell cycle distribution after drug exposure by high content imaging analysis using low-toxic DNA staining dyeKazuma Takeuchi, Yumiko Nishimura, Takayoshi Matsubara, et al.
International Journal of Colorectal Disease|September 13, 2020
Serum IL-8 level as a candidate prognostic marker of response to anti-angiogenic therapy for metastatic colorectal cancerMitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, et al.
Biological & Pharmaceutical Bulletin|September 15, 2012
Development of an immunohistochemical protein quantification system in conjunction with tissue microarray technology for identifying predictive biomarkers for phosphatidylinositol 3-kinase inhibitorsSho Isoyama, Hisashi Yoshimi, Shingo Dan, et al.
Journal of the American Chemical Society|June 8, 2022
Structural Determination, Total Synthesis, and Biological Activity of Iezoside, a Highly Potent Ca<sup>2+</sup>-ATPase Inhibitor from the Marine Cyanobacterium <i>Leptochromothrix valpauliae</i>Naoaki Kurisawa, Arihiro Iwasaki, Kazuya Teranuma, et al.
Biochemical and Biophysical Research Communications|July 12, 2023
Invivo anti-cancer activity of 10-methyl-aplog-1, a simplified analog of aplysiatoxin, and its possible signaling pathway associated with G1 arrestYusuke Hanaki, Yuki Shikata, Masayuki Kikumori, et al.
Biological & Pharmaceutical Bulletin|November 3, 2009
Identification of candidate genes determining chemosensitivity to anti-cancer drugs of gastric cancer cell linesTomoki Nakamura, Noriyuki Nakatsu, Yoko Yoshida, et al.
RSC Advances|June 10, 2022
Structure-antitumor activity relationship of hybrid acetogenins focusing on connecting groups between heterocycles and the linker moietyKaito Ohta, Tetsuya Fushimi, Mutsumi Okamura, et al.
Cancer Science|August 29, 2012
Establishment of phosphatidylinositol 3-kinase inhibitor-resistant cancer cell lines and therapeutic strategies for overcoming the resistanceSho Isoyama, Shingo Dan, Yumiko Nishimura, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|June 16, 2016
M-COPA, a novel Golgi system disruptor, suppresses apoptosis induced by Shiga toxinTakayuki Hattori, Miho Watanabe-Takahashi, Isamu Shiina, et al.
The Journal of Antibiotics|October 29, 2015
Pyrrocidine A, a metabolite of endophytic fungi, has a potent apoptosis-inducing activity against HL60 cells through caspase activation via the Michael additionShota Uesugi, Nozomi Fujisawa, Jun Yoshida, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Pharmacology Research & Perspectives|April 29, 2024
Prediction of cell cycle distribution after drug exposure by high content imaging analysis using low-toxic DNA staining dyeKazuma Takeuchi, Yumiko Nishimura, Takayoshi Matsubara, et al.
International Journal of Colorectal Disease|September 13, 2020
Serum IL-8 level as a candidate prognostic marker of response to anti-angiogenic therapy for metastatic colorectal cancerMitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, et al.
Biological & Pharmaceutical Bulletin|September 15, 2012
Development of an immunohistochemical protein quantification system in conjunction with tissue microarray technology for identifying predictive biomarkers for phosphatidylinositol 3-kinase inhibitorsSho Isoyama, Hisashi Yoshimi, Shingo Dan, et al.
Journal of the American Chemical Society|June 8, 2022
Structural Determination, Total Synthesis, and Biological Activity of Iezoside, a Highly Potent Ca<sup>2+</sup>-ATPase Inhibitor from the Marine Cyanobacterium <i>Leptochromothrix valpauliae</i>Naoaki Kurisawa, Arihiro Iwasaki, Kazuya Teranuma, et al.
Biochemical and Biophysical Research Communications|July 12, 2023
Invivo anti-cancer activity of 10-methyl-aplog-1, a simplified analog of aplysiatoxin, and its possible signaling pathway associated with G1 arrestYusuke Hanaki, Yuki Shikata, Masayuki Kikumori, et al.
Biological & Pharmaceutical Bulletin|November 3, 2009
Identification of candidate genes determining chemosensitivity to anti-cancer drugs of gastric cancer cell linesTomoki Nakamura, Noriyuki Nakatsu, Yoko Yoshida, et al.
RSC Advances|June 10, 2022
Structure-antitumor activity relationship of hybrid acetogenins focusing on connecting groups between heterocycles and the linker moietyKaito Ohta, Tetsuya Fushimi, Mutsumi Okamura, et al.
Cancer Science|August 29, 2012
Establishment of phosphatidylinositol 3-kinase inhibitor-resistant cancer cell lines and therapeutic strategies for overcoming the resistanceSho Isoyama, Shingo Dan, Yumiko Nishimura, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|June 16, 2016
M-COPA, a novel Golgi system disruptor, suppresses apoptosis induced by Shiga toxinTakayuki Hattori, Miho Watanabe-Takahashi, Isamu Shiina, et al.
The Journal of Antibiotics|October 29, 2015
Pyrrocidine A, a metabolite of endophytic fungi, has a potent apoptosis-inducing activity against HL60 cells through caspase activation via the Michael additionShota Uesugi, Nozomi Fujisawa, Jun Yoshida, et al.
Pageof 9